Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» HER2-low breast cancer
HER2-low breast cancer
Surprise Enhertu rejection follows NICE process change
Pharmaphorum
Tue, 03/5/24 - 11:35 am
AstraZeneca
Daiichi Sankyo
HER2-low breast cancer
Enhertu
NICE
UK
The problem with Her2-low testing
EP Vantage
Mon, 11/28/22 - 07:34 pm
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
diagnostics
HER2-low breast cancer
Roche nets FDA approval for HER2-low breast cancer test paired with AstraZeneca-Daiichi's Enhertu
Fierce Biotech
Wed, 10/5/22 - 07:07 pm
Roche
FDA
diagnostics
Medtech
HER2-low breast cancer
Enhertu
AstraZeneca
Daiichi Sankyo
FDA approves AstraZeneca, Daiichi drug in breast cancer first
BioPharma Dive
Sun, 08/7/22 - 11:24 pm
AstraZeneca
Daiichi Sankyo
breast cancer
Enhertu
FDA
HER2-low breast cancer
ASCO22: Enhertu aces key HER2-low test in breast cancer
Pharmaforum
Mon, 06/6/22 - 09:43 am
ASCO 2022
AstraZeneca
Daiichi Sankyo
Enhertu
HER2-low breast cancer
breast cancer
Big day for AZ, Daiichi as Enhertu aces HER2-low breast cancer trial
Pharmaforum
Mon, 02/21/22 - 10:35 am
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
HER2-low breast cancer
breast cancer
